• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Improved mortality rates for myocardial infarction, stroke, and pulmonary embolism in patients receiving dialysis between 1998 to 2015

byYuchen DaiandMichael Pratte
April 22, 2022
in Cardiology, Chronic Disease, Nephrology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Between 1998 to 2015, mortality rates for myocardial infarction, stroke, and pulmonary embolism decreased more in patients receiving dialysis than in the general population.

2. This improvement in mortality rate may be due to better predialysis and dialysis care.

Evidence Rating Level: 2 (Good)

Study Rundown: It is unclear whether advancements in the prevention and management of myocardial infarction, stroke, and pulmonary embolism in the general population over the past decades have also benefited patients receiving dialysis. This cohort study evaluated the trends in mortality rates for myocardial infarction, stroke, and pulmonary embolism in patients receiving dialysis compared with the general population. The main outcomes were age- and sex-standardized mortality rate ratios (SMRs) with 95%CIs comparing the mortality rates in patients receiving dialysis vs the general population for 3 periods (1998-2003, 2004-2009, and 2010-2015). Compared with the general population, SMRs for myocardial infarction, stroke, and pulmonary embolism decreased more in patients receiving dialysis, possibly owing to improvements in predialysis and dialysis care. A limitation of this study was the lack of information on comorbidities, medication use, and laboratory data resulting in residual confounding to the mortality trends detected.

Click to read the study in JAMA Network Open

Relevant Reading: Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients

In-Depth [retrospective cohort]: This cohort study included 220 467 adult patients (median [IQR] age, 68.2 [56.5-76.4] years; 82 068 [37.2%] female) who received dialysis between 1998-2015 from 11 European countries providing data to the European Renal Association. After 3-year follow-up, 83 912 patients died, of whom 7662 (9.1%) died from myocardial infarction, 5030 (6.0%) from stroke, and 435 (0.5%) from pulmonary embolism. Comparing the period between 1998-2003 and 2010-2015, the SMR of myocardial infarction decreased from 8.1 (95%CI, 7.8-8.3) to 6.8 (95%CI, 6.5-7.1), the SMR of stroke decreased from 7.3 (95%CI, 7.0-7.6) to 5.8 (95%CI, 5.5-6.2), and the SMR of pulmonary embolism decreased from 8.7 (95%CI, 7.6-10.1) to 5.5 (95%CI, 4.5-6.6).

RELATED REPORTS

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

Ophthalmologic procedures are not associated with increased risk for acute myocardial infarction

Reduced bleeding risk with asundexian compared to apixaban in patients with atrial fibrillation

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: dialysishemodialysismyocardial infarctionstroke
Previous Post

Rilzabrutinib demonstrates rapid and durable clinical activity for immune thrombocytopenia

Next Post

Widespread population immunity of Covid-19 observed in South Africa before Omicron wave

RelatedReports

FDA-approved weight loss medications associated with weight loss at one year
Cardiology

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

May 25, 2022
Nonpowder gun-related pediatric eye injuries on the rise
Cardiology

Ophthalmologic procedures are not associated with increased risk for acute myocardial infarction

April 22, 2022
Stroke expansion following intra-arterial therapy may explain worse outcomes
Cardiology

Reduced bleeding risk with asundexian compared to apixaban in patients with atrial fibrillation

April 19, 2022
#VisualAbstract: Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis
StudyGraphics

#VisualAbstract: Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis

April 14, 2022
Next Post
Novel coronavirus identified from patients with pneumonia in Wuhan, China

Widespread population immunity of Covid-19 observed in South Africa before Omicron wave

#VisualAbstract: Odronextamab shows promising clinical activity in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

#VisualAbstract: Odronextamab shows promising clinical activity in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Awake prone positioning may not offer clinical benefits among patients hospitalized with COVID-19-associated hypoxemia

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.